MENU
+Compare
PMCUF
Stock ticker: OTC
AS OF
Dec 2 closing price
Price
$174.66
Change
-$5.34 (-2.97%)
Capitalization
17.95B

PMCUF stock forecast, quote, news & analysis

Pro Medicus is a healthcare IT company specializing in radiology imaging software... Show more

PMCUF
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for PMCUF with price predictions
Nov 28, 2025

PMCUF's RSI Oscillator recovers from oversold territory

The RSI Oscillator for PMCUF moved out of oversold territory on November 12, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 21 similar instances when the indicator left oversold territory. In of the 21 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 21 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Moving Average Convergence Divergence (MACD) for PMCUF just turned positive on November 19, 2025. Looking at past instances where PMCUF's MACD turned positive, the stock continued to rise in of 38 cases over the following month. The odds of a continued upward trend are .

PMCUF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 19, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on PMCUF as a result. In of 70 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PMCUF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for PMCUF entered a downward trend on November 28, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. PMCUF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: PMCUF's P/B Ratio (112.360) is slightly higher than the industry average of (21.322). P/E Ratio (249.569) is within average values for comparable stocks, (104.811). PMCUF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.426). Dividend Yield (0.002) settles around the average of (0.028) among similar stocks. P/S Ratio (135.135) is also within normal values, averaging (66.972).

A.I.Advisor
published Dividends

PMCUF paid dividends on October 01, 2021

Pro Medicus, Ltd. PMCUF Stock Dividends
А dividend of $0.08 per share was paid with a record date of October 01, 2021, and an ex-dividend date of September 09, 2021. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Teladoc Health (NYSE:TDOC).

Industry description

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

Market Cap

The average market capitalization across the Services to the Health Industry Industry is 2.2B. The market cap for tickers in the group ranges from 9 to 39.52B. VEEV holds the highest valuation in this group at 39.52B. The lowest valued company is MDPEF at 9.

High and low price notable news

The average weekly price growth across all stocks in the Services to the Health Industry Industry was -1%. For the same Industry, the average monthly price growth was -6%, and the average quarterly price growth was 4%. RMHI experienced the highest price growth at 78%, while MITI experienced the biggest fall at -36%.

Volume

The average weekly volume growth across all stocks in the Services to the Health Industry Industry was -53%. For the same stocks of the Industry, the average monthly volume growth was -82% and the average quarterly volume growth was -44%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 56
P/E Growth Rating: 70
Price Growth Rating: 63
SMR Rating: 84
Profit Risk Rating: 95
Seasonality Score: 19 (-100 ... +100)
View a ticker or compare two or three
PMCUF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry ServicestotheHealthIndustry

Profile
Fundamentals
Details
Industry
N/A
Address
450 Swan Street
Phone
+61 394298800
Employees
76
Web
https://www.promed.com.au